Inventor · disambiguated record
Stanley J. Korsmeyer
Also filed as: KORSMEYER STANLEY · KORSMEYER STANLEY J
32 granted patents·7 pending applications·1,449 citations·filing 1993–2018
98Inventor score
Files withUNIV WASHINGTON15DANA FARBER CANCER INST INC11WALENSKY LOREN D4GOLUB TODD R2BERNAL FEDERICO1
Top patents by PatentIndex Score
39 records- 0198US9902759B2BH3 peptides and methods of use thereofDANA FARBER CANCER INST INC·Filed 2016·Granted Feb 27, 2018·25 cites·8 claims
- 0298US8796418B2Stabilized alpha helical peptides and uses thereofWALENSKY LOREN D·Filed 2008·Granted Aug 5, 2014·73 cites·30 claims
- 0397US8198405B2Stabilized alpha helical peptides and uses thereofWALENSKY LOREN D·Filed 2008·Granted Jun 12, 2012·67 cites·19 claims
- 0497US7868133B2BH3 peptides and method of use thereofDANA FARBER CANCER INST INC·Filed 2007·Granted Jan 11, 2011·46 cites·6 claims
- 0597US7723469B2Stabilized alpha helical peptides and uses thereofDANA FARBER CANCER INST INC·Filed 2004·Granted May 25, 2010·151 cites·1 claims
- 0696US9273099B2Stabilized alpha helical peptides and uses thereofWALENSKY LOREN D·Filed 2011·Granted Mar 1, 2016·35 cites·36 claims
- 0796US5856445ASerine substituted mutants of BCL-XL /BCL-2 associated cell death regulatorUNIV WASHINGTON·Filed 1996·Granted Jan 5, 1999·169 cites·18 claims
- 0895US9527896B2Stabilized p53 peptides and uses thereofDANA FARBER CANCER INST INC·Filed 2014·Granted Dec 27, 2016·31 cites·15 claims
- 0995US9464115B2Stabilized alpha helical peptides and uses thereofDANA FARBER CANCER INST INC·Filed 2013·Granted Oct 11, 2016·29 cites·32 claims
- 1094US8889632B2Stabilized p53 peptides and uses thereofBERNAL FEDERICO·Filed 2008·Granted Nov 18, 2014·61 cites·25 claims
- 1194US7247700B2BID polypeptides and methods of inducing apoptosisDANA FARBER CANCER INST INC·Filed 2002·Granted Jul 24, 2007·82 cites·4 claims
- 1294US5998583ABH3 interacting domain death agonistUNIV WASHINGTON·Filed 1997·Granted Dec 7, 1999·113 cites·15 claims
- 1394US5691179ACell death regulatorsUNIV WASHINGTON·Filed 1993·Granted Nov 25, 1997·45 cites·20 claims
- 1493US7829662B2Method of treating apoptosis and compositions thereofDANA FARBER CANCER INST INC·Filed 2007·Granted Nov 9, 2010·28 cites·4 claims
- 1593US5955593ABH3 interacting domain death agonistUNIV WASHINGTON·Filed 1996·Granted Sep 21, 1999·100 cites·16 claims
- 1692US5834209ABcl-x/bcl-2 associated cell death regulatorUNIV WASHINGTON·Filed 1996·Granted Nov 10, 1998·81 cites·20 claims
- 1791US9856303B2BH3 peptides and method of use thereofKORSMEYER STANLEY J·Filed 2010·Granted Jan 2, 2018·25 cites·3 claims
- 1891US5622852ABcl-x/Bcl-2 associated cell death regulatorUNIV WASHINGTON·Filed 1994·Granted Apr 22, 1997·84 cites·9 claims
- 1988US10202431B2Stabilized P53 peptides and uses thereofDANA FARBER CANCER INST INC·Filed 2016·Granted Feb 12, 2019·6 cites·17 claims
- 2087US11225511B2BH3 peptides and methods of use thereofDANA FARBER CANCER INST INC·Filed 2018·Granted Jan 18, 2022·4 cites·18 claims
- 2187US7011947B2MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemiaDANA FARBER CANCER INST INC·Filed 2002·Granted Mar 14, 2006·24 cites·7 claims
- 2284US6326354B1Modulation of apoptosis with bidUNIV WASHINGTON·Filed 1998·Granted Dec 4, 2001·84 cites·6 claims
- 2378US5856171ACell death regulatorsUNIV WASHINGTON·Filed 1994·Granted Jan 5, 1999·32 cites·12 claims
- 2475US10716828B2Methods of modulating cellular homeostatic pathways and cellular survivalDANIAL NIKA N·Filed 2008·Granted Jul 21, 2020·3 cites·14 claims
- 2573US7964700B2Inhibitors of Taspase1 protease activityDANA FARBER CANCER INST INC·Filed 2007·Granted Jun 21, 2011·1 cites·24 claims
- 2669US5955595ACell death regulatorsUNIV WASHINGTON·Filed 1997·Granted Sep 21, 1999·11 cites·6 claims
- 2767US6165732AMethod for identifying apoptosis modulating compoundsUNIV WASHINGTON·Filed 1998·Granted Dec 26, 2000·24 cites·10 claims
- 2864US2003096367A1Cell death agonistsFiled 2002·Application pending·0 cites
- 2964US2004171809A1BH3 peptides and method of use thereofFiled 2003·Application pending·0 cites
- 3059US2017008930A1Stabilized alpha helical peptides and uses thereofWALENSKY LOREN D·Filed 2016·Application pending·0 cites
- 3156US2006068482A1Taspase1 and methods of useHSIEH JAMES J·Filed 2004·Application pending·0 cites
- 3253US6500626B1Cell death regulatorsUNIV WASHINGTON·Filed 1999·Granted Dec 31, 2002·4 cites·14 claims
- 3353US2006057630A1MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemiaGOLUB TODD R·Filed 2005·Application pending·0 cites
- 3453US2005085420A1Method of modulating apoptosis and compositions thereofFiled 2004·Application pending·0 cites
- 3553US2006024734A1MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemiaGOLUB TODD R·Filed 2005·Application pending·0 cites
- 3645US5942490ACell death regulatorsUNIV WASHINGTON·Filed 1997·Granted Aug 24, 1999·2 cites·26 claims
- 3744US6184202B1Cell death regulatorsUNIV WASHINGTON·Filed 1997·Granted Feb 6, 2001·2 cites·10 claims
- 3843US5700638ACell death regulatorUNIV WASHINGTON·Filed 1994·Granted Dec 23, 1997·6 cites·21 claims
- 3935US5850002AAnimal models for loss and gain of Hox11 functionUNIV WASHINGTON·Filed 1996·Granted Dec 15, 1998·1 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →